ALLIANCEBERNSTEIN L.P. - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 45 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q1 2024$46,260
+26.0%
18,0000.0%0.00%
Q4 2023$36,720
+18.6%
18,0000.0%0.00%
Q3 2023$30,960
-11.8%
18,0000.0%0.00%
Q2 2023$35,100
-79.8%
18,000
-57.3%
0.00%
Q1 2022$174,000
-67.8%
42,200
+0.2%
0.00%
Q4 2021$541,000
+52.0%
42,100
+27.6%
0.00%
Q3 2021$356,000
+18.3%
33,0000.0%0.00%
Q2 2021$301,000
+30.9%
33,000
+35.2%
0.00%
Q1 2021$230,000
+42.9%
24,400
-40.2%
0.00%
Q4 2020$161,000
+49.1%
40,8000.0%0.00%
Q3 2020$108,000
-63.6%
40,800
-8.9%
0.00%
Q2 2020$297,000
+92.9%
44,800
+69.7%
0.00%
Q1 2020$154,000
-7.8%
26,400
+41.9%
0.00%
Q4 2019$167,000
+3.7%
18,6000.0%0.00%
Q3 2019$161,000
+10.3%
18,600
+42.0%
0.00%
Q2 2019$146,000
-48.8%
13,100
-34.5%
0.00%
Q3 2018$285,00020,0000.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$9,152,1568.87%
Affinity Asset Advisors, LLC 2,390,600$6,143,8420.76%
Redmile Group, LLC 5,755,075$14,790,5430.54%
IRONWOOD INVESTMENT MANAGEMENT LLC 157,603$405,0400.20%
Frazier Life Sciences Management, L.P. 1,030,878$2,649,3560.11%
Artal Group S.A. 1,030,952$2,649,5470.07%
TWIN PEAKS WEALTH ADVISORS, LLC 40,314$103,6070.06%
Artia Global Partners LP 95,170$244,5870.05%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 247,607$636,3500.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$197,4040.03%
View complete list of GRITSTONE ONCOLOGY INC shareholders